Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 40, 2022 - Issue 12
Journal homepage
2,426
Views
16
CrossRef citations to date
0
Altmetric
Research Articles

Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study

Khadijeh Ahmadia Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; ORCID Iconhttps://orcid.org/0000-0003-4669-0708View further author information
ORCID Icon,
Alireza Farasatb Cellular and Molecular Research Center, Research Institute for Prevention of Non Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran; ;c Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran; View further author information
,
Mosayeb Rostamiand Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; ORCID Iconhttps://orcid.org/0000-0002-1071-7019View further author information
ORCID Icon,
Behrooz Joharie Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran; View further author information
&
Hamid Madanchif Department of Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran; ;g Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6527-7321View further author information
ORCID Icon
Pages 5566-5576 | Received 11 Sep 2020, Accepted 30 Dec 2020, Published online: 13 Jan 2021

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Masoumeh Sadat Mousavi Maleki, Mosayeb Rostamian & Hamid Madanchi. (2021) Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2. Expert Review of Anti-infective Therapy 19:10, pages 1205-1217.
Read now
Danwei Yu, Yuanmei Zhu, Hongxia Yan, Tong Wu, Huihui Chong & Yuxian He. (2021) Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus. Emerging Microbes & Infections 10:1, pages 810-821.
Read now

Articles from other publishers (14)

Yanchao Liu, Youzhuo Zhu, Xin Sun, Tianyue Ma, Xingzhen Lao & Heng Zheng. (2023) DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins. Viruses 15:4, pages 820.
Crossref
D. S. N. B. K. Prasanth, Gagandeep Singh, Siva Prasad Panda, Suneetha Achanti, Hemant Soni, Tapan K. Chaudhuri, Harshal Ashok Pawar & Md Jahasultana. (2022) In Silico Screening of Plant-Derived Anti-virals from Shorea hemsleyana (King) King ex Foxw Against SARS CoV-2 Main Protease. Chemistry Africa 6:1, pages 345-366.
Crossref
Yongliang Yuan, Baihai Jiao, Lili Qu, Duomeng Yang & Ruijuan Liu. (2023) The development of COVID-19 treatment. Frontiers in Immunology 14.
Crossref
Chiara Stefani, Tobia Fantoni, Michele Bissoli, Jordan Thomas & Alessandra Ruggiero. (2022) HIV and SARS-CoV-2 Co-Infection: From Population Study Evidence to In Vitro Studies. Life 12:12, pages 2089.
Crossref
Masoumeh Sadat Mousavi Maleki, Soroush Sardari, Ali Ghandehari Alavijeh & Hamid Madanchi. (2022) Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals. International Journal of Peptide Research and Therapeutics 29:1.
Crossref
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Yalda Yazdani, Omid Gholizadeh, Raheleh Tabatabaie, Hamed Afkhami, Fatemeh Davodabadi, Alireza Khanalipour farkhad, Daryoush Pahlevan, Akram Firouzi-Amandi, Kazem Nejati-Koshki & Mehdi Dadashpour. (2022) An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. Journal of Nanobiotechnology 20:1.
Crossref
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei & Awat Feizi. (2022) Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies. Canadian Journal of Infectious Diseases and Medical Microbiology 2022, pages 1-70.
Crossref
Samaneh Namvar Arabani, Hamid Madanchi, Hatef Ajoudanifar & Ali Akbar Shabani. (2022) Evaluation of Antibacterial, Antifungal, and Cytotoxicity Effects of CecropinA-Magenin2 (CE-MA) Peptide and Its Truncated Derivatives and Study of Their Action Mechanism. International Journal of Peptide Research and Therapeutics 28:4.
Crossref
Pritam V. Bagwe, Priyal V. Bagwe, Sai Srinivas Ponugoti & Shreerang V. Joshi. (2022) Peptide-Based Vaccines and Therapeutics for COVID-19. International Journal of Peptide Research and Therapeutics 28:3.
Crossref
Trina Ekawati Tallei, Fatimawali, Ahmad Akroman Adam, Mona M. Elseehy, Ahmed M. El-Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, Nurdjannah Jane Niode, Diah Kusumawaty, Souvia Rahimah, Yunus Effendi, Rinaldi Idroes, Ismail Celik, Md. Jamal Hossain & Talha Bin Emran. (2022) Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach. Molecules 27:1, pages 260.
Crossref
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi & Reza Mirnejad. (2022) A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis. Informatics in Medicine Unlocked 28, pages 100862.
Crossref
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi & Reza Mirnejad. (2021) In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Omid Haghighi. (2021) In Silico Study of the Structure and Ligand Preference of Pyruvate Kinases from Cyanobacterium Synechocystis sp. PCC 6803. Applied Biochemistry and Biotechnology 193:11, pages 3651-3671.
Crossref
Jianmin Chen, Fayaz Ali, Imran Khan & Yi Zhun Zhu. (2021) Recent progress in the development of potential drugs against SARS-CoV-2. Current Research in Pharmacology and Drug Discovery 2, pages 100057.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.